Cargando…
Tumor Infiltrating Lymphocytes and NHERF1 Impact on Prognosis of Breast Cancer Patients
BACKGROUND: Breast cancer (BC) is a heterogeneous disease, and patients with apparently similar clinicopathological characteristics in clinical practice show different outcome. This study evaluated in primary BCs and in the subgroup of the triple-negative breast cancers (TNBCs) the level of tumor in...
Autores principales: | Schirosi, Laura, Saponaro, Concetta, Giotta, Francesco, Popescu, Ondina, Pastena, Maria Irene, Scarpi, Emanuela, Mangia, Anita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6931214/ https://www.ncbi.nlm.nih.gov/pubmed/31865181 http://dx.doi.org/10.1016/j.tranon.2019.10.020 |
Ejemplares similares
-
NHERF1 and tumor microenvironment: a new scene in invasive breast carcinoma
por: Saponaro, Concetta, et al.
Publicado: (2018) -
Should Tumor Infiltrating Lymphocytes, Androgen Receptor, and FOXA1 Expression Predict the Clinical Outcome in Triple Negative Breast Cancer Patients?
por: Mangia, Anita, et al.
Publicado: (2019) -
NHERF1 together with PARP1 and BRCA1 expression as a new potential biomarker to stratify breast cancer patients
por: Mangia, Anita, et al.
Publicado: (2017) -
Prognostic Value of NLRP3 Inflammasome and TLR4 Expression in Breast Cancer Patients
por: Saponaro, Concetta, et al.
Publicado: (2021) -
NHERF1 Between Promises and Hopes: Overview on Cancer and Prospective Openings()
por: Centonze, Matteo, et al.
Publicado: (2018)